Home › Funds › Marshall Wace › NVAX
Marshall Wace position in NVAX
NOVAVAX INC · Health Care
Latest position (Q2 2026)652.87K sh
Reported value held$6.15M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 15.86K | $3.29M | New |
| Q4 2021 | 45.59K | $6.52M | Add |
| Q1 2022 | 16.55K | $1.22M | Reduce |
| Q2 2022 | 160.16K | $8.23M | Add |
| Q2 2024 | 362.69K | $4.59M | New |
| Q3 2024 | 148.92K | $1.88M | Reduce |
| Q3 2025 | 51.59K | $447.33K | New |
| Q4 2025 | 930.01K | $6.25M | Add |
| Q1 2026 | 1.17M | $9.49M | Add |
| Q2 2026 | 652.87K | $6.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NVAX
- BlackRock Inc 13.95M sh · $131.38M · Q2 2026
- Vanguard Group 15.47M sh · $103.96M · Q4 2025
- D. E. Shaw & Co 6.03M sh · $56.82M · Q2 2026
- Geode Capital Management 4.21M sh · $39.64M · Q2 2026
- Two Sigma Investments 4.09M sh · $38.54M · Q2 2026
- Coatue Management 3.84M sh · $36.14M · Q2 2026
- Citadel Advisors 3.81M sh · $35.90M · Q2 2026
- Bank of America Corp 3.42M sh · $32.18M · Q2 2026
- Goldman Sachs Group 3.38M sh · $31.87M · Q2 2026
- UBS Group AG 2.24M sh · $21.11M · Q2 2026
- Millennium Management 1.79M sh · $16.87M · Q2 2026
- Northern Trust Corp 1.45M sh · $13.64M · Q2 2026